Back to Agenda
SESSION 12: THE FDA AND RISK MANAGEMENT
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- Pre-marketing risk assessment
- Post-marketing risk assessment
- Risk evaluation and mitigation strategies
Speaker(s)
THE FDA AND RISK MANAGEMENT
Carol H. Danielson, DrPH, MS, RAC
Regulatory Advantage, LLC, United States
President
Have an account?